As part of PDA’s ongoing commitment to the future of the pharmaceutical industry, the 2020 PDA Advanced Therapy Medicinal Products (ATMPs) Conference will provide a broad overview of current innovations with a focus on successful stewardship of cell and gene therapies toward approval and beyond. The Conference will be an ideal forum for sharing best practices and learning how industry is applying novel approaches to product development, manufacturing, and regulatory compliance for long-term success.
Plenary sessions will discuss the current state of the science and emphasize real-world challenges companies face as they integrate process development, quality, manufacturing, regulatory strategies, and supply chain given the unique requirements of ATMPs. The sessions will provide insight into industry best practices including next generation processing, analytical methods, quality systems implementation, control strategy and its link to product realization, quality risk management, aseptic processing, and regulatory compliance.
Don’t miss out on this important learning opportunity. Make plans now to attend the 2020 PDA Advanced Therapy Medicinal Products Conference.